Marc Hedrick
Physician and biotech executive serving as President and CEO of Plus Therapeutics, with a background in surgery and experience leading companies developing radiotherapeutics and diagnostics for CNS cancers.
Best podcasts with Marc Hedrick
Ranked by the Snipd community
Mar 16, 2026 • 54min
Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.
Marc Hedrick, M.D., a surgeon-turned-biotech CEO leading Plus Therapeutics. He explains the company pivot to radiotherapeutics for brain cancers. He discusses why Rhenium-186 and Reyobiq were chosen, liposomal delivery and tumor retention, supply chain advantages, and the acquisition of CNSide diagnostics to improve CNS cancer detection and monitoring.
